Navigation Links
Top Heart Programs Choose Safety of Medivance's Non-Invasive Arctic Sun(R) for Therapeutic Hypothermia
Date:12/9/2008

Best hospitals adhere to trend in medicine favoring non-invasive interventions that minimize needless complications

LOUISVILLE, Colo., Dec. 9 /PRNewswire/ -- The nation's top-rated heart programs continue to favor the non-invasive, safe and technologically advanced Arctic Sun Temperature Management System from Medivance for cooling critically ill patients.

Cooling comatose cardiac arrest survivors is an evidence-based standard of care recommended by the American Heart Association.

"Therapeutic hypothermia is the single most effective intervention to improve neurologic outcome after out-of-hospital cardiac arrest," says Brian O'Neil, MD, Emergency Department Research Director at Beaumont Hospital in Royal Oak, Michigan, ranked among the nation's top 15 heart programs. "Our experience with it has been outstanding, as the data we recently presented at the American College of Emergency Physicians Research Forum and the Society of Academic Emergency Medicine meetings indicate."

The preference for the Arctic Sun is in keeping with the strong trend in medicine toward least invasive methods. Consequently, more than half of the 50 heart programs ranked best in the nation by U.S. News & World Report now use the Arctic Sun to quickly induce hypothermia and then slowly rewarm their critically ill patients. In the topmost ranks, 80 percent of the 20 top hospitals prefer the safety and precision of Medivance's non-invasive device.

"We use the Arctic Sun for two reasons. It's non-invasive, and it's extremely reliable for maintaining temperature within the narrow range required for maximum therapeutic benefit," Dr. O'Neil says.

The non-invasive Arctic Sun System avoids the unnecessary risks associated with invasive cooling catheters. And because nurses initiate the therapy, cooling begins quickly when minutes count.

Arctic Sun users ranked among best heart programs, move up in rankings

Six hospitals that use the Arctic Sun were added to the U.S. News & World Report list ofbest 50 heart programs, and five others saw their rankings rise in the past two years.

"That the majority of the nation's best-rated heart hospitals prefer the safety, ease of use and efficiency of the Arctic Sun clearly substantiates the Arctic Sun's market leadership," says Medivance CEO Robert Kline. "Our rapidly growing customer base in community and academic medical centers worldwide is another indication that the Arctic Sun continues to be the premier cooling device benefitting the greatest number of people."

About Medivance's Arctic Sun

The non-invasive Arctic Sun Temperature Management System precisely monitors and maintains core body temperature in a therapeutic range, between 32 degrees and 38.5 degrees Celsius (approximately 89.6 degrees to 101.3 degrees Fahrenheit) with the potential to minimize damage to the heart and brain. The patented design of the Arctic Sun and ArcticGel(TM) Pads enables them to transfer up to five times more thermal energy than conventional products such as water blankets, wraps or ice packs, resulting in more efficient temperature management. The system's precision also enables the slow rewarming thought to be critical to therapeutic benefit. The Arctic Sun has received 510(k) FDA clearance in the U.S., the European Union's CE Mark, marketing approval in Japan and other global markets. Medivance develops and manufactures non-invasive, proprietary therapeutic temperature management solutions. More information at www.medivance.com.

Photos available for download at http://www.medivance.com/html/Media/medLibrary.html


'/>"/>
SOURCE Medivance
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Mediterranean Diet Enriched With Nuts Cuts Heart Risks
2. Womens Death Rate Higher From Severe Heart Attack
3. Double threat: Deadly lung disease also linked to heart attacks
4. Study finds treatment fails to improve common form of heart failure
5. The ESC launches a new release of HeartScore
6. UCSF Medical Center Leads Nation in ER Heart Attack Care
7. Rapid Response Teams Dont Cut Hospital Heart Attacks, Death Rates
8. Light Drinking Poses No Heart Risk for Women
9. Generic Heart Drugs as Good as Brand-Name Counterparts
10. Mini heart attacks lessen damage from major ones
11. Vitamin D Vital for the Heart
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... 18, 2017 , ... The CHP suggests that California drivers can avoid hydroplaning ... down and increasing the space between themselves and other vehicles, according to a January ... Raymond R. Hassanlou notes that, rain or shine, drivers should always incorporate safe driving ...
(Date:1/19/2017)... Norwalk, CT (PRWEB) , ... January 19, 2017 , ... ... Dr. Sang H. Kim, a highly experienced and compassionate dermatologist. Dr. Kim brings ... skincare center . , “It is with considerable pleasure to welcome back Dr. Kim ...
(Date:1/19/2017)... ... 19, 2017 , ... Sales Focus Inc. (SFI), a Maryland-based sales outsourcing company, ... Over the past 20 years SFI has been recognized as the world’s leader in ... clients into the US market. The new clients include: Panacea Pro, Campseekers, Contentmart, ...
(Date:1/19/2017)... Seabrook, NH (PRWEB) , ... January 19, 2017 , ... ... develop its business plan and implement new sales and marketing strategies. Grover comes with ... spent the last 5 and a half years as Executive Vice President of Direct ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... the American Osteopathic College of Proctology) announced today the opening of 3 ... California ( http://www.hemorrhoidsremovalcenterscalifornia.com ): Hemorrhoids Center of Los Angeles (Beverly Hills), Hemorrhoids ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017 The U.S. Food and ... Chronic Idiopathic Constipation (CIC) in adult patients. ... gastrointestinal disorders," said Julie Beitz , M.D., director of ... for Drug Evaluation and Research. "With the availability of new ... treatment for their condition." ...
(Date:1/19/2017)... 2017  Stealth BioTherapeutics Inc. ( Stealth ), a ... today announced new additions to its senior leadership team: ... Officer, and Daniel Geffken as interim Chief ... Carr , Pharm.D. has been promoted to Chief Clinical ... welcome Doug and Daniel to our management team, as ...
(Date:1/19/2017)... 2017 James Gilbart ... Haematology, 2016;12(Suppl 2):3-8; http://www.touchoncology.com/articles/optimising-clinical-outcomes-gastrointestinal-cancers-through-inhibiting-angiogenesis-and ... ... Published recently in a supplement to European Oncology ... an article by James Gilbart and ...
Breaking Medicine Technology: